Industry Insights
Specialty drug pipeline
Leading expert insights on specialty pharmacy medications
Here are 10 growth-driver specialty medications we are closely tracking, educating our hospital and health system partners about and actively seeking for formulary additions to make available to patients as soon as possible.
Recent FDA approvals for 2025 included 46 novel (brand new) drugs, bringing new treatment options to patients and filling gaps in unmet medical needs. Of the novel drugs approved:
43% are classified as first-in-class, which means they introduce new mechanisms of action to treat specific medical conditions
50% are orphan drugs developed to treat rare diseases and often a small number of patients
2025 Report
Here are 10 growth driver specialty medications we closely tracked and educated our hospital and health system partners about in 2025.
Download report >WHITE PAPERS
Innovating with specialty pharmacy clinical programs
Beyond HIV Viral Supression: The Role of Health System Specialty Pharmacists in Providing Comprehensive Care for People Living with HIV
Download paper >
Towards Eliminating Hepatitis C as a Public Health Threat in the United States
Download paper >